Since its founding in 1994, Discovery Therapeutics Inc. has managed to get five products into the clinic on a paltry $12 million budget. On Tuesday it announced the closing of its fourth round of financing, raising $45 million. "This round closed in the middle of August," said Kenneth Rice, vice president and chief commercial officer at Discovery. "We did it in a very difficult market so we think it was a remarkable …

No comments:
Post a Comment